AMPD1 Antibody

中文名稱：

AMPD1兔多克隆抗體
貨號：

CSB-PA001680LA01HU
規格：

￥440
圖片：
Western Blot
Positive WB detected in: MCF-7 whole cell lysate, PC-3 whole cell lysate, A549 whole cell lysate
All lanes: AMPD1 antibody at 3μg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 91, 90 kDa
Observed band size: 91 kDa
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品名稱：

Rabbit anti-Homo sapiens (Human) AMPD1 Polyclonal antibody
Uniprot No.：

P23109
基因名：

AMPD1
別名：

AMPD1AMP deaminase 1 antibody; EC 3.5.4.6 antibody; AMP deaminase isoform M antibody; Myoadenylate deaminase antibody
宿主：

Rabbit
反應種屬：

Human
免疫原：

Recombinant Human AMP deaminase 1 protein (97-272AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產品，AMPD1 Antibody (CSB-PA001680LA01HU)，的標記方式是Non-conjugated。對于AMPD1 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產品名稱	應用
HRP	CSB-PA001680LB01HU	AMPD1 Antibody, HRP conjugated	ELISA
FITC	CSB-PA001680LC01HU	AMPD1 Antibody, FITC conjugated
Biotin	CSB-PA001680LD01HU	AMPD1 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:5000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

AMP deaminase plays a critical role in energy metabolism.
基因功能參考文獻：
1. T allele of AMPD1 gene C34T polymorphism may be correlated with LVEF, LVEDD and SBP, which plays a protective role in the cardiac functions and blood pressure in cardiovascular disease patients. PMID: 28673246
2. The metabolic-chronotropic response is decreased in skeletal muscle MAD deficiency, suggesting a biological mechanism by which AMPD1 gene exerts cardiac effect PMID: 29095874
3. Variations in AMPD1, CPT2, and PGYM genes are not associated with the onset, susceptibility, or severity of chronic fatigue syndrome. PMID: 27525900
4. Common polymorphism of the AMPD1 gene (C34T) is strongly associated with essential hypertension. PMID: 27323204
5. AMPD1 could have a profound influence on cholinergic neurotransmission and sleep; further studies are mandatory PMID: 26439223
6. AMPD1 34C>T variant is associated with higher infection susceptibility to community acquired pneumonia but not to ventilator associated pneumonia in sepsis pateints PMID: 26529652
7. Mutational variants in AMPD1 contribute to autism risk in Han Chinese population, via mitochondria dysfunction and cell necrosis. PMID: 25155876
8. The best response to creatine in terms of physical performance was presented by AMPD1 CC genotype. PMID: 25665401
9. The present study demonstrated a positive effect of C34T AMPD1 gene polymorphism in aortic stiffness and in inflammatory status in a high risk population of CAD subjects. PMID: 24508110
10. Our other studies on the metabolic impact of AMPD1 C34T mutation revealed decrease in AMPD activity. PMID: 24431031
11. Alpinists show significantly higher frequencies of T allele compared to controls. PMID: 24058088
12. AMPD1 gene polymorphism C34T can be considered as a marker of liability to the high-speed and strength muscular activity. PMID: 23486588
13. In a study of a Spanish and 2 North African cohorts, frequency of the AMPD1 C34T mutation was lower in Berbers compared with the Alpujarra cohort. The GDF8 K153R substitution showed little variability among the three cohorts. PMID: 22324844
14. There was a lower frequency of the AMPD1 exon 2 T34 allele in elite Polish power-oriented athletes. The data suggested that the C allele may help athletes to attain elite status in power-oriented sports. PMID: 22017426
15. The researchers found evidence that the T allele polymorphism of the AMPD1 gene is associated with negative factor in athletic performance PMID: 22105616
16. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases. PMID: 21108053
17. some physico-chemical properties of AMP-deaminase isolated from cardiac muscle of a 10-year-old boy heterozygote for this mutation PMID: 20544536
18. A G468T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. PMID: 12117480
19. Significantly higher frequency of mutation among donors with healthy hearts used for transplantation. Lower frequency in dysfunctional donor hearts. Frequency of C34T mutation in chronic heart failure was not different. (Review) PMID: 15239633
20. The AMPD1 C34T polymorphism influences transplant-free cardiovascular survival in the setting of ischemic left ventricular dysfunction. PMID: 15309698
21. Primary myoadenylate-deaminase deficiency was diagnosed based upon elevated creatine-kinase, absent staining for MAD on muscle biopsy, markedly reduced MAD activity in the muscle homogenate, and C34T mutation within exon 2 of AMPD1 gene. PMID: 15368811
22. In conclusion, although the frequency distribution of the mutant T allele of the AMPD1 genotype is lower in Caucasian elite endurance athletes than in controls, the C34T mutation does not significantly impair endurance performance. PMID: 15677729
23. In this study, the metabolic clearance rate of insulin was associated with AMPD1 SNPs and haplotypes. PMID: 15793265
24. a C34T mutation in AMP deaminase is found more frequently in healthy donor hearts than in healthy controls or donors with failing hearts PMID: 16021915
25. the AMPD1 mutation decreases the activity of AMP-deaminase in the heart without changing the activity of any other enzymes of adenine nucleotide metabolism PMID: 16021918
26. The interpretation of the significance of these observations suggests a physiological mutual dependence between skeletal muscle HPRG and AMPD polypeptides with regard to their stability. PMID: 16570231
27. Genes are associated with good clinical response of rheumatoid arthritis to methotrexate treatment. PMID: 16947783
28. We did not demonstrate any effect of the C34T polymorphism of the AMPD1 gene on major congestive heart failure parameters and on survival. PMID: 16996850
29. The 34C > T variant of AMPD1 augments vasodilation and reduces tissue injury in response to forearm ischaemia. These mechanisms could contribute to the survival benefit of cardiovascular patients with this variant allele. PMID: 17376785
30. Reveals a functional role for skeletal muscle AMPD1 enzyme in sprint exercise. PMID: 17463303
31. C34T and G468T variations in the adenosine monophosphate deaminase-1 (AMPD1) gene were associated with intima-media thickness of the carotid and brachial artery, endothelial function of the brachial artery in patients with coronary heart disease. PMID: 17565237
32. Results suggest a better circulatory adaptation to exercise in individuals with diminished AMPD1 activity, probably due to an AMPD1 genotype-dependent increase in adenosine formation. PMID: 18224333
33. may control the systemic metabolic status by changing AMPK activity through the AMP level. PMID: 18409530
34. This is a first report evidencing the pattern of AMPD genes expression in neoplastic human liver. PMID: 18493842
35. C34T AMPD1 polymorphism may be associated with reduced frequency of obesity in coronary artery disease(CAD) patients and of hyperglycaemia and diabetes in both CAD and heart failure patients. PMID: 18855224
36. We found statistical significance for ACE ID and II genotypes in soccer players than in runners; Statistical significance was also reached for AMPD1 (with higher frequency of CT genotype in soccer players than in runners [chi(2)((2))=7.538, P=0.006]) PMID: 19277943
37. Possession of AMPD1 T allele is associated with decreased inotropic requirements before heart donation. Incidence of graft dysfunction was significantly higher in recipients who received AMPD1 T-allele-possessing organs resulting in worse 1-year survival. PMID: 19427446
38. Observational study of gene-disease association, pharmacogenomic / toxicogenomic, and genetic testing. (HuGE Navigator) PMID: 17530705
顯示更多

收起更多
相關疾病：

Myopathy due to myoadenylate deaminase deficiency (MMDD)
蛋白家族：

Metallo-dependent hydrolases superfamily, Adenosine and AMP deaminases family
數據庫鏈接：

HGNC: 468

OMIM: 102770

KEGG: hsa:270

STRING: 9606.ENSP00000430075

UniGene: Hs.89570

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human